Glucagon-like peptide 1 receptor agonist use and vertebral fracture risk in type 2 diabetes
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-May-2026 10:15 ET (24-May-2026 14:15 GMT/UTC)
Metabolic dysfunction-associated steatotic liver disease (MASLD), a spectrum of liver conditions ranging from simple steatosis to steatohepatitis (MASH), fibrosis, and cirrhosis, represents a global health epidemic with no approved pharmacotherapies.